CSS
Cubist Systematic Strategies’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-84,202
| Closed | -$2.92M | – | 2095 |
|
|
2024
Q2 | $2.92M | Buy |
84,202
+78,207
| +1,305% | +$2.71M | 0.02% | 473 |
|
|
2024
Q1 | $173K | Buy |
+5,995
| New | +$173K | ﹤0.01% | 1713 |
|
|
2023
Q2 | – | Sell |
-64,978
| Closed | -$1.49M | – | 2863 |
|
|
2023
Q1 | $1.49M | Buy |
64,978
+13,472
| +26% | +$310K | 0.01% | 1263 |
|
|
2022
Q4 | $562K | Buy |
51,506
+32,477
| +171% | +$354K | ﹤0.01% | 2120 |
|
|
2022
Q3 | $160K | Hold |
19,029
| – | – | ﹤0.01% | 3072 |
|
|
2022
Q2 | $151K | Sell |
19,029
-9,107
| -32% | -$72.3K | ﹤0.01% | 3281 |
|
|
2022
Q1 | $666K | Buy |
28,136
+27,590
| +5,053% | +$653K | 0.01% | 2332 |
|
|
2021
Q4 | $19K | Sell |
546
-571
| -51% | -$19.9K | ﹤0.01% | 3378 |
|
|
2021
Q3 | $20K | Sell |
1,117
-2,783
| -71% | -$49.8K | ﹤0.01% | 2887 |
|
|
2021
Q2 | $175K | Sell |
3,900
-10,800
| -73% | -$485K | ﹤0.01% | 2607 |
|
|
2021
Q1 | $381K | Buy |
+14,700
| New | +$381K | ﹤0.01% | 2109 |
|
|
2020
Q3 | – | Sell |
-22,085
| Closed | -$390K | – | 2607 |
|
|
2020
Q2 | $390K | Buy |
+22,085
| New | +$390K | 0.01% | 1713 |
|
|
2019
Q4 | – | Sell |
-21,992
| Closed | -$264K | – | 2518 |
|
|
2019
Q3 | $264K | Buy |
+21,992
| New | +$264K | 0.01% | 1616 |
|
|
2018
Q2 | – | Sell |
-11,593
| Closed | -$100K | – | 1991 |
|
|
2018
Q1 | $100K | Buy |
11,593
+8,327
| +255% | +$71.8K | 0.01% | 1590 |
|
|
2017
Q4 | $68K | Buy |
+3,266
| New | +$68K | ﹤0.01% | 1747 |
|